Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Cambridge Cognition, developer of computerised neuropsychological tests, to go public in the UK

cantabmobileCam­bridge Cog­ni­tion, one of the 10 Com­pa­nies to Watch in 2013/ 2014 accord­ing to our lat­est mar­ket report, just announced its plans to go pub­lic in the UK’s AIM market.

Cam­bridge Cog­ni­tion in £15M AIM IPO (Busi­ness Weekly): “… the move will value the busi­ness at around £15 mil­lion. It is hoped the shares will be admit­ted to AIM on April 8…The group devel­ops and com­mer­cialises com­put­erised neu­ropsy­cho­log­i­cal tests for sale world­wide, prin­ci­pally in the UK – its main coun­try of oper­a­tion – the US and Europe…CCL has two estab­lished prod­uct streams, CANTAB­elect (for clin­i­cal research and tri­als) and CANTABeclipse (for aca­d­e­mic and other research)…A third prod­uct, CANTAB­mo­bile, an approved Class II med­ical device, was launched in the UK in May 2012.”

To Learn More:

Be Socia­ble, Share!
    Print This Article Print This Article

    Categories: Cognitive Neuroscience, Health & Wellness, Technology

    Tags: , , , , ,

    Welcome to SharpBrains.com

    As seen in The New York Times, The Wall Street Jour­nal, CNN and more, Sharp­Brains is an inde­pen­dent mar­ket research firm track­ing health and well­ness appli­ca­tions of brain science.
    FIRST-TIME VISITOR? Dis­cover HERE the most pop­u­lar resources at SharpBrains.com

    Gold Sponsors @ 2014 SharpBrains Virtual Summit (October 28-30th)

    Follow us via

    twitter_logo_header
    Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:
    Join more than 50,000 Sub­scribers and stay informed and engaged.